PEN News and Press, Penumbra Inc. From 07/09/23

2023-07-09 18:15:18 ET Acumen Pharmaceuticals ( NASDAQ: ABOS ), Establishment Labs ( NASDAQ: ESTA ), Arcus Biosciences ( NYSE: RCUS ) and BridgeBio Pharma ( NASDAQ: BBIO ) are four of BTIG's top picks for small and mid-cap healthcare stocks going into the lat...

Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023 PR Newswire ALAMEDA, Calif. , July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financia...

Penumbra, Inc. (NYSE: PEN) is the focus of IBN's latest stock spotlight. The company's shares have moved -0.67% on the day to $336.51. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based throm...

(NewsDirect) Pennant International (LON:PEN) chief executive Philip Walker speaks to Thomas Warner from Proactive about how the training technology and integrated product support solutions business has been performing since he took over as CEO back in 2018. He explains the rationale for t...

2023-06-22 14:10:31 ET Summary Penumbra, Inc. has seen continued, steady, and impressive top-line sales growth over the past decade. This sales growth is now resulting in modest profits on the bottom line as well. I like the business a lot, but Penumbra shares have more than d...

2023-06-22 00:34:20 ET Summary Penumbra, Inc. continues pushing higher, and I have revised my price target of $490. The company's fundamental drivers, sentimental factors, and valuation all indicate further value could be obtained. PEN is expected to see 25% growth at the top ...

2023-06-14 16:42:19 ET Summary AngioDynamics and Merit Medical came together for a $100M transaction that will transfer ANGO's hemodialysis and BioSentry products to Merit. Merit is gaining more scale and adding specialty products in an already-important dialysis business, and thi...

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration PR Newswire Lightning Bolt™ 7 is the most advanced arterial thrombectomy system on the market Latest technology c...

Penumbra, Inc. (NYSE: PEN) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.28% on the day to $310.41. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thromb...

Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference PR Newswire ALAMEDA, Calif. , May 24, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43 rd An...